Cheng et al. [27] observed that the RASSF1C-PIWI-piRNA pathway promotes lung cancer cell growth and progression and suggests that PIWIL1 protein is abnormally expressed in various types of cancer, making it a potential biomarker and therapeutic target. This evidence concerns the gene PIWIL1 and lung carcinoma.